欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）
MR编号LV/H/0215/001
药品名称Ondansetron Kalceks 2 mg/ml solution for injection/infusion
活性成分
    • ondansetron hydrochloride 2.0 mg/ml
剂型Solution for injection/infusion
上市许可持有人Akciju sabiedrība Kalceks Krustpils Iela 53, Riga, LV-1057 Latvia
参考成员国 - 产品名称Latvia (LV)
Ondansetron Kalceks 2 mg/ml šķīdums injekcijām/infūzijām
互认成员国 - 产品名称
    • United Kingdom (Northern Ireland) (XI)
    • Germany (DE)
      Ondansetron Kalceks
    • Finland (FI)
    • Denmark (DK)
      Ondansetron Kalceks
    • Poland (PL)
      ONDANSETRON KALCEKS
    • Belgium (BE)
      Ondansetron Kalceks 2 mg/ml solution injectable/pour perfusion
    • Lithuania (LT)
      Ondansetron Kalceks 2 mg/ml injekcinis ar infuzinis tirpalas
    • Netherlands (NL)
    • Estonia (EE)
      ONDANSETRON KALCEKS
    • Iceland (IS)
      Ondansetron Kalseks
    • Hungary (HU)
      Ondansetron Kalceks 2 mg/ml oldatos injekció vagy infúzió
    • Ireland (IE)
    • Bulgaria (BG)
      Ondansteron Kalceks
    • Austria (AT)
      Ondansetron Kalceks 2 mg/ml Injektions-/Infusionslösung
    • Czechia (CZ)
      Ondansetron Kalceks
    • Spain (ES)
    • Romania (RO)
      Ondansetron Kalceks 2 mg/ml soluţie injectabilă/perfuzabilă
    • Italy (IT)
    • Slovakia (SK)
    • Greece (GR)
    • Slovenia (SI)
    • Sweden (SE)
    • Croatia (HR)
    • Norway (NO)
      Ondansetron Kalceks
许可日期2021/07/12
最近更新日期2024/06/21
药物ATC编码
    • A04AA01 ondansetron
申请类型
  • TypeLevel1：Abridged
  • TypeLevel2：Initial Application
  • TypeLevel3：Generic Art 10.1 and 10.2 Dir 2001/83/EC
  • TypeLevel4：Chemical Substance
  • TypeLevel5：Prescription Only
附件文件下载
市场状态Positive
©2006-2024 Drugfuture->European Union HMA Authorisation of Medicines DataBase